Evidence map›Paper›PMID 42657916›Full record

ArticleASN neuro2026

CD44 Knockout Alters the Cellular Response and Improves Locomotor Outcome After Spinal Cord Injury.

Dana Creasman, Francisca Benavente, Rebecca Nishi, Aileen Anderson

Abstract read
In one paragraph

Article in ASN neuro, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dana CreasmanSue and Bill Gross Stem Cell Research Center, University of California Irvine, Irvine, CA, USA.
Francisca BenaventeSue and Bill Gross Stem Cell Research Center, University of California Irvine, Irvine, CA, USA.
Rebecca NishiSue and Bill Gross Stem Cell Research Center, University of California Irvine, Irvine, CA, USA.
Aileen AndersonSue and Bill Gross Stem Cell Research Center, University of California Irvine, Irvine, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinal cord injury (SCI) is a devastating condition that results in long-term functional impairments due to loss of tissue and limited regeneration. Investigating the factors that regulate the post-SCI response is critical to understanding the pathophysiology of this condition and developing treatments. One molecule of interest in the post-SCI response is CD44. CD44 is cell-surface protein with a well-established role in regulating cellular functions including cell migration and proliferation. CD44 is expressed in many cells that play a role in the post-SCI microenvironment but the effect of global CD44 KO on SCI outcomes has not previously been tested. Here, we investigate that role in a mouse unilateral cervical contusion SCI model. We predicted that CD44 KO would exert a predominant effect on glial progenitor/cell recruitment, inhibiting astroglial scar formation and thereby increasing lesion expansion and exacerbating locomotor deficits. In contrast, we found that CD44 KO mice exhibited increased numbers of astrocytes at the lesion epicenter, developed a more compact astroglial scar by 28 days after injury, showed improved locomotor function, and exhibited decreased recruitment of acutely activated immune cells vs WT mice. Together, these findings highlight the role of CD44 in diverse cell populations after SCI as a critical point of further investigation to understand the post-SCI response.

Indexed as

Hyaluronan ReceptorsLocomotionRecovery of FunctionSpinal Cord InjuriesAnimalsAstrocytesDisease Models, AnimalFemaleGlial Fibrillary Acidic ProteinMiceMice, Inbred C57BLMice, KnockoutCd44 protein, mouseGlial Fibrillary Acidic ProteinHyaluronan ReceptorsC1qCd44ComplementNeural stem cellsNeuroimmuneSpinal cord injury

Identifiers

PMID42657916
PMCPMC13523994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.